206 related articles for article (PubMed ID: 23793731)
21. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).
Malliaras K; Makkar RR; Smith RR; Cheng K; Wu E; Bonow RO; Marbán L; Mendizabal A; Cingolani E; Johnston PV; Gerstenblith G; Schuleri KH; Lardo AC; Marbán E
J Am Coll Cardiol; 2014 Jan; 63(2):110-22. PubMed ID: 24036024
[TBL] [Abstract][Full Text] [Related]
22. Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI).
Sürder D; Schwitter J; Moccetti T; Astori G; Rufibach K; Plein S; Lo Cicero V; Soncin S; Windecker S; Moschovitis A; Wahl A; Erne P; Jamshidi P; Auf der Maur C; Manka R; Soldati G; Bühler I; Wyss C; Landmesser U; Lüscher TF; Corti R
Am Heart J; 2010 Jul; 160(1):58-64. PubMed ID: 20598973
[TBL] [Abstract][Full Text] [Related]
23. Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis.
Fisher SA; Dorée C; Brunskill SJ; Mathur A; Martin-Rendon E
PLoS One; 2013; 8(6):e64669. PubMed ID: 23840302
[TBL] [Abstract][Full Text] [Related]
24. [Stem cells after myocardial infarction].
Schächinger V; Dimmeler S; Zeiher AM
Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
[TBL] [Abstract][Full Text] [Related]
25. Cell therapy for acute myocardial infarction.
Wollert KC
Curr Opin Pharmacol; 2008 Apr; 8(2):202-10. PubMed ID: 18243051
[TBL] [Abstract][Full Text] [Related]
26. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells.
Zenovich AG; Davis BH; Taylor DA
Handb Exp Pharmacol; 2007; (180):117-65. PubMed ID: 17554507
[TBL] [Abstract][Full Text] [Related]
27. [Systematic review on safety of intracoronary autologous bone marrow stem cells transfer in patients with acute myocardial infarction].
Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):679-84. PubMed ID: 19100106
[TBL] [Abstract][Full Text] [Related]
28. [Stem cell therapy in ischemic heart disease].
Diederichsen AC; Møller JE; Kristiansen MA; Saekmose SG; Barington T; Videbaek LM; Kassem MS; Thayssen P
Ugeskr Laeger; 2006 Mar; 168(11):1111-4. PubMed ID: 16545213
[TBL] [Abstract][Full Text] [Related]
29. Beta-blockers in patients without heart failure after myocardial infarction.
Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
[TBL] [Abstract][Full Text] [Related]
30. Stem cell therapy in acute myocardial infarction.
Janssens S
Acta Clin Belg; 2007; 62(5):342-7. PubMed ID: 18229469
[TBL] [Abstract][Full Text] [Related]
31. Stem cells for myocardial repair.
Siu CW; Liao SY; Liu Y; Lian Q; Tse HF
Thromb Haemost; 2010 Jul; 104(1):6-12. PubMed ID: 20352151
[TBL] [Abstract][Full Text] [Related]
32. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
33. Responder Definition in Clinical Stem Cell Trials in Cardiology: Will the Real Responder Please Stand Up?
Zwetsloot PP; Gremmels H; Assmus B; Koudstaal S; Sluijter JP; Zeiher AM; Chamuleau SA
Circ Res; 2016 Aug; 119(4):514-8. PubMed ID: 27492842
[No Abstract] [Full Text] [Related]
34. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
35. Cell therapy in myocardial infarction.
Collins SD; Baffour R; Waksman R
Cardiovasc Revasc Med; 2007; 8(1):43-51. PubMed ID: 17293268
[TBL] [Abstract][Full Text] [Related]
36. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.
Wallach JD; Wang K; Zhang AD; Cheng D; Grossetta Nardini HK; Lin H; Bracken MB; Desai M; Krumholz HM; Ross JS
BMJ; 2020 Feb; 368():l7078. PubMed ID: 32024657
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Yu J; Zhang RF; Mao YL; Zhang H
Curr Stem Cell Res Ther; 2022; 17(8):793-807. PubMed ID: 34397334
[TBL] [Abstract][Full Text] [Related]
38. Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction.
Tendera M; Wojakowski W
Folia Histochem Cytobiol; 2005; 43(4):233-5. PubMed ID: 16382891
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
40. Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.
Afzal MR; Samanta A; Shah ZI; Jeevanantham V; Abdel-Latif A; Zuba-Surma EK; Dawn B
Circ Res; 2015 Aug; 117(6):558-75. PubMed ID: 26160853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
